Remotely Triggered Nano-Theranostics For Cancer Applications

Abstract

Nanotechnology has enabled the development of smart theranostic platforms that can concurrently diagnose disease, start primary treatment, monitor response, and, if required, initiate secondary treatments. Recent in vivo experiments demonstrate the promise of using theranostics in the clinic. In this paper, we review the use of remotely triggered theranostic nanoparticles for cancer applications, focusing heavily on advances in the past five years. Remote triggering mechanisms covered include photodynamic, photothermal, phototriggered chemotherapeutic release, ultrasound, electro-thermal, magneto-thermal, X-ray, and radiofrequency therapies. Each section includes a brief overview of the triggering mechanism and summarizes the variety of nanoparticles employed in each method. Emphasis in each category is placed on nano-theranostics with in vivo success. Some of the nanotheranostic platforms highlighted include photoactivatable multi-inhibitor nanoliposomes, plasmonic nanobubbles, reduced graphene oxide-iron oxide nanoparticles, photoswitching nanoparticles, multispectral optoacoustic tomography using indocyanine green, low temperature sensitive liposomes, and receptor-targeted iron oxide nanoparticles loaded with gemcitabine. The studies reviewed here provide strong evidence that the field of nanotheranostics is rapidly evolving. Such nanoplatforms may soon enable unique advances in the clinical management of cancer. However, reproducibility in the synthesis procedures of such “smart” platforms that lend themselves to easy scale-up in their manufacturing, as well as the development of new and improved models of cancer that are more predictive of human responses, need to happen soon for this field to make a rapid clinical impact.

Nano-Therapies for Glioblastoma Treatment

“…These nano-systems can also be associated with fluorescent/radioactive compounds to enable their localization in the organism [9]. On top of that, it may in some cases be possible to activate these nano-systems on demand by deciding to apply (or not) an external source of energy such as X-rays, ultrasounds, or alternating magnetic field [10]. Figure 1 summarizes how such structures are built up, while Table 1 presents various nano-systems used for GBM treatment, with their backbone composition, functionalization/coating, mechanism of action, and efficacy demonstrated in vitro and/or in vivo.…”

Multifunctional Magnetic Nanowires: Design, Fabrication, and Future Prospects as Cancer Therapeutics

“…It is important to note the role of magnetic NW in theranostics, a paradigm shift promoting personalization of treatment through the combination of diagnostics and therapeutics. The role of magnetic NW platforms in therapeutics encompasses targeted and triggered release drug delivery, photothermal therapy, and magnetic actuation systems as discussed above [59]. In terms of diagnostics, the large surface area of NW increases the efficacy of fluorescence labelling while in terms of magnetic NW, it increases the magnetic moment, making it attractive in fluorescence imaging and magnetic resonance imaging (MRI), respectively.…”

Prototypic Heptamethine Cyanine Incorporating Nanomaterials for Cancer Phototheragnostic

“…The development of devices that simultaneously allow the diagnosis and treatment (theragnostic) of cancer has been the focus of different studies performed by worldwide researchers. In this context, light‐responsive nanomaterials with theragnostic capabilities have been displaying promising results toward both in vitro and in vivo preclinical cancer models . This therapeutic modality employs nanostructures with well‐defined physicochemical properties that confer them with the ability to preferentially accumulate within the tumor .…”